CURIS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CURIS, INC. (CRIS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-24
- CURIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.70M, a 85.71% decline from fiscal 2024.
- CURIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $11.90M, a 11.85% decline from fiscal 2023.
- CURIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $13.50M, a 21.97% decline from fiscal 2022.
- CURIS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $17.30M, a 170.31% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.70M 10-K · filed 2026-03-24 | |
| 2024-12-31 | $11.90M 10-K · filed 2025-03-31 | |
| 2023-12-31 | $13.50M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $17.30M 10-K · filed 2024-02-08 | |
| 2021-12-31 | $6.40M 10-K · filed 2023-03-13 | -$6.40M 10-K · filed 2022-02-24 |
| 2020-12-31 | $1.20M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $9.60M 10-K · filed 2021-03-16 | |
| 2018-12-31 | $6.30M 10-K · filed 2020-03-19 | |
| 2017-12-31 | -$31.40M 10-K · filed 2019-03-26 | |
| 2016-12-31 | $30.00M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $23.40M 10-K · filed 2018-03-08 | |
| 2014-12-31 | $7.00M 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |